Skip to main content

Table 1 Effects of 5 weeks treatment with telmisartan (TELM) given either alone or combined with praziquantel (PZQ) on hepatomesenteric worm load and oogram pattern (% egg developmental stages) of mice infected with Schistosoma mansoni and sacrificed at the 10 th (set 1) and 15 th (set 2) weeks post infection

From: Telmisartan, an AT1 receptor blocker and a PPAR gamma activator, alleviates liver fibrosis induced experimentally by Schistosoma mansoni infection

  

Set 1

   

Set 2

   
  

Infected control

TELM-treated

PZQ-treated

TELM+PZQ-treated

Infected control

TELM-treated

PZQ-treated

TELM+PZQ-treated

Hepatomesenteric worm load

Male

5.25±0.12

5.75±0.51

1.17±0.08*@

0.72±0.03*@

3.86±0.28

4.56±0.06

0.63±0.03* @

1.10±0.09* @

Female

1.75±0.13

1.88±0.04

0.17±0.01*@

0.14±0.01*@

1.86±0.11

1.67±0.13

0.00±0.00*@

0.00±0.00*@

Couple

4.00±0.41

3.25±0.37

0.00±0.00*@

0.00±0.00*@

3.72±0.08

3.56±0.18

0.00±0.00*@

0.00±0.00*@

Total

15.00±1.08

14.25±0.88

1.33±0.12*@

0.86±0.03*@

12.57±0.65

12.56±0.41

0.63±0.03*@

1.10±0.08*@

% Egg developmental stages

Immature

48.00±2.00

52.13±0.74

0.00±0.00*@

0.00±0.00*@

40.57±0.61

38.67±1.29

0.00±0.00*@

0.00±0.00*@

Mature

44.75±1.93

41.00±0.54

4.17±2.00*@

3.29±0.01*@

36.57±1.11

35.22±1.73

1.00±0.05*@

0.70±0.02*@

 

Dead

7.25±0.02

6.88±0.48

95.83±2.01*@

96.72±0.72*@

19.58±1.56

20.33±0.67

99.13±0.44*@

98.60±0.65*@

  1. Mice were infected with 60±10 cercariae/mouse, injected subcutaneously. Telmisartan (TELM; 10 mg/kg/day, p.o.) was given at the 5th (set 1) and 10th (set 2) weeks post infection for 5 weeks. Praziquantel (PZQ; 500 mg/kg/day, p.o.) was given at the 7th week post infection for 2 consecutive days. Animals were sacrificed at the end of TELM treatment. Data are represented as mean ± S.E.M. (n = 8–10). Significant difference (P < 0.05) * versus infected control group and @ versus TELM-treated group.